farmacon-global-logo

The Rare DIEM (Rare Diseases In Emerging Markets) Alliance was created to promote research in emerging markets like Latin America! The alliance brings together researchers and doctors who want to get involved in clinical research opportunities.

We are excited to connect with medical professionals across Latin America and Central America who are interested in learning and contributing to cutting-edge clinical research. Your expertise and insights are invaluable in advancing medical knowledge and improving patient care. By joining our alliance, you will be connected to potential research projects that will benefit your professional development, your patients and the greater community.

Please take a moment to fill out this form so we can learn more about you!


Sara Tylosky, MBA
CEO

Sara Tylosky, MBA, CEO at Farmacon Global, brings over 20 years of experience leading teams in both large and small pharmaceutical and biotech environments. She has led Farmacon Global, a strategic CRO of medical consultants, in accelerating clinical trials, increasing diversity, supporting enrollment, and paving the way to market access in emerging markets.

Known for her high cultural intelligence and problem-solving skills, Sara and her team specialize in Rare Diseases, Immunology, Infectious Diseases, Cancer, and Vaccines. Fluent in Spanish and having lived on four continents, she has a special focus on Latin America while actively expanding into other key markets globally. Sara’s direction plays a pivotal role in steering Farmacon Global toward healthcare innovation and global market leadership.